Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |